Updates

  1. 137 new fund letters and reports, each with its own page: Kayne Anderson Rudnick (48 market briefings, KayneCast episodes and TV commentaries), Shelton Capital Management (48 shareholder reports and a commentary), Lakehouse Capital (10 Small Companies Fund letters), Smead (5 newsletters), RIT Capital Partners (5 monthly commentaries), Kovitz, Legal & General, Generation, Hosking, Marram, Munro, Oldfield and others.
  2. 200 new fund letters and reports, each with its own page: Spheria (41 monthly reports), Peapack Private (41 weekly recaps and planning newsletters), Fort Washington (23), Polen Capital (15), Aristotle Pacific (14), Riverwater (13), Chou (10), Apollo Asia Fund (8, back to 1998), Personal Asset Trust, Rockwood Strategic, J Capital Research, I/O Fund, Penn Davis McFarland, Pomona and others.
  3. Investor pages have one Investments tab with shares, changes, % owned, class, market cap and Market cap and Status filters, a Funds tab listing each fund the firm runs, and assets under management from Form ADV. The Investors table shows AUM and current investments, and its search finds investors by what they hold.
  4. Filters, search and sort stay as you left them when you come back to a section. Person cards look like book cards. Company pages name their Investors tab Ownership. Kind and Sector filters use four kinds and GICS sectors with industries. Dead links left the Links tabs.
  5. 190 more investors from fiscal.ai's list, with their sites, letters, partners and 13F holdings; 556 more partner descriptions. Experts now lists only people.
  6. Fund letters lists 144 new documents from 23 firms, each with its own page: a summary, key insights and quotes. Among them: 37 BlackRock articles, 21 Value Partners monthly notes, eight Baron Capital letters, six Stone Sentinel letters to partners, seven Value Line portfolio manager Q&As, BNY's 2026 earnings releases and Starboard Value's 2026 conference presentations.
  7. 584 more investors, with their websites, 6,776 letters from their own sites, 1,385 partners with pages and the 13F holdings of 213 firms. New letters arrive daily from 290 more archives.
  8. Media and Companies filter by GICS sector and industry group, taken from the companies an episode or page names. 1,860 more company pages show a logo, the SEC's list included.
  9. The home page counts what the platform holds and lists features such as the document reader, the player and saved marks. Settings sits at the foot of the rail. Book cards are a quarter wider, so rows hold fewer. Companies drops the Named in filter, and the Role list in your account runs A to Z.
  10. Investor pages of 13 firms show their newsroom's latest posts. New 13F filings are read as the SEC publishes them.
  11. Investor pages have an Investments tab: 13,975 holdings for 105 investors, from their 13F filings with the SEC and their own portfolio pages, with status and sector. 7,338 more companies have a page of their own.
  12. A podcast or YouTube episode keeps playing while you move around the site, in a bar with skip, speed and volume. Media tables show each episode's length and description.
  13. Press releases come from each company's own newsroom (167 companies); SEC filings sit on the Filings tab. Tickers name their exchange, and a company's Experts tab includes guests whose episode description names it.
  14. Letter types now include Market commentary, Fact sheet, Interim report, Annual report, Proxy circular and Governance document. The reader opens over the whole window.
  15. Partners of investment firms have 2,836 appearances and 580 pieces of writing on their pages; Derek Sivers's page lists every book he rates, with his rating.
  16. Fund letters lists three Akre Focus shareholder reports: the ETF's annual report for the year to July 2026, its semi-annual report to January 2026 and the fund's semi-annual report to January 2025, each with its own page: a summary, key insights and quotes.
  17. 837 partners of 73 investment firms now have their own pages, with title, description, photograph and social accounts; Andreessen Horowitz partners' pages also list their writing on a16z.com.
  18. Company pages have a Press releases tab: 8,229 releases for 203 companies, from SEC filings and company newsrooms. Companies filter by For-profit or Non-profit. Own media is a table with filters. Media filters by sector and industry. Publication pages link their publisher in the description.
  19. The Unilever page's Letters tab shows what each fund letter says about Unilever, word for word with its page, and whether the letter is bullish, bearish, mixed or neutral. Filter by sentiment, and see 10 letters at a time.
  20. 492 more fund letters and 3,183 more articles show the day they were published, read from each letter's first page or each article's own page.
  21. The PDF reader has a search box: type words to see every match in the document and step through them. About 540 letters that were web pages, among them Oakmark's commentaries, Bill Miller's letters and Howard Marks's memos, now open in the reader.
  22. Person pages: recommendations open with tier 1 books; one button per organisation; transcripts sit on their episodes; the books on 129 reading lists joined the Recommends tabs.
  23. Companies lists every company with a ticker on the SEC's list, with a Source filter. A quote on a company page opens the letter at that page with the words marked. A company's Media tab lists only episodes that name it, and a new Own media tab lists its podcasts, publications and YouTube channel. Show pages link their publisher. A page opened from a table no longer shows that table's filters beside it.
  24. Company, investor and person pages show more of their social accounts: Facebook, TikTok, Bluesky, Medium, GitHub, Discord and podcast shows. Investor pages list every partner the firm's own team page names: 965 people across 73 investors, 98 for Andreessen Horowitz.
  25. About 170 more letters and papers open in the reader: Mohnish Pabrai's letters and transcripts from his site's new folder, and free copies of papers by Asness, Harvey, Altman, Lo and others from their own or their schools' sites.
  26. Every company a fund letter names has a page, with the letters and quotes that name it: 47 new pages, among them Atom Computing, Hugging Face, Rolls-Royce Holdings and Westinghouse Electric. Company pages have a Quotes tab.
  27. A person's Writing tab has a Type column and filter (Article, Essay, Transcript, Speech, Foreword, Interview and the rest), and Publication names only the publication that published each piece.
  28. Fund letters opens on the newest published letter, and a letter or paper found by search opens its own page here instead of the publisher's site.
  29. A letter or paper with a copy on the site opens its PDF over its page, with a button to open it in a new tab. Select text to highlight or underline it; signed-in readers keep their marks in their account. Each quote opens the PDF at its page with its words marked, and a Source link leads to the publisher's original.
  30. Fund letters lists 61 more documents, each with its own page: Fairfax's 2025 and 2026 interim reports, proxy circulars and 2025 annual report (with their French editions), 26 Charlie Munger meeting transcripts, talks and essays, Third Point's 2026 monthly reports and Malibu Life's interim results, and a Seth Klarman interview. Papers adds Richard Thaler's two 2020 editorials on nudges.
  31. Fund letters lists Lux Capital's letters for Q2 and Q3 2026, by Josh Wolfe, each with its own page: a summary, key insights and quotes.
  32. Fund letters lists Brookfield's letter to shareholders for Q3 2026, by Bruce Flatt, with its own page: a summary, key insights and quotes.
  33. Fund letters lists Howard Marks's memo of 11 November 2026, A Layman Thinks About AI, with its own page: a summary, key insights and quotes.
  34. Fund letters lists 118 more letters, each with its own page: 44 weekly commentaries by Jeremy Siegel from 2026, 31 issues of Van Tharp's newsletter from 2018, 23 Pabrai Investment Funds letters from 2021 to Q3 2026, 13 Efficient Frontier essays by William Bernstein, Oakmark's three 3Q 2026 commentaries, two Lindsell Train reports, a John Hussman comment and Third Point's Q3 2026 letter.
  35. 2,027 more books carry a one-line description in the Books table and on their pages; 7,067 of 7,715 have one, every tier 1, 2 and 3 book among them.
  36. Fund letters lists 187 more letters from 19 firms, among them Permanent Equity, Social Capital, Lux Capital, Square Peg, Bestinver, Cobas, Sequoia Fund, Marketfield and EquityCompass; each shows on its investor's page and has a page of its own.
  37. 2,928 more books carry a one-line description in the Books table and on their pages, so every tier 1, 2 and 3 book has one; 5,040 in all.
  38. Every publication on Newsletters has its own page: its writing, its writers, its staff and who recommends it. Investor pages have a Management tab; a company's Experts tab now leaves out its own people, who list under Management. Tabs on a phone move sideways only.
  39. Every fund letter and research paper has its own page: the thesis, the PDF, the companies and books it names, and for 176 letters and 24 papers so far a summary, key insights and quotes with their page.
  40. 99 books that no page listed now sit under their topics in Books, among them Caste, American Prometheus and Pale Blue Dot.
  41. Newsletters lists every newspaper, magazine, investment newsletter, journal and blog the reference holds, 442 in all, with the people who write there. The search box keeps your last 20 searches. You can create an account.
  42. 283 books that fund managers recommend in their letters are on the shelf, each with the letter's own words and page; investor pages have a Recommends tab.
  43. Person, company, investor and show pages link their own accounts on X, Threads, Instagram, LinkedIn, YouTube and Substack: 275 people, 552 companies and organisations, 88 investors and 478 shows.
  44. 716 more book recommendations name their source: the person's own reading list, letter, blog post, speech or interview, or an article that reports it. 232 of them quote the person's own words about the book, on the book card and on the book's page.
  45. Every US-listed company has a page with its SEC filings. Company pages list their experts and their management, past and present. Fund managers sit under Investors. Each show has a page of its episodes, and an episode page names its guests and hosts. Biographies lists groups, then people. Breadcrumbs show where a page sits.
  46. Media lists every podcast episode, video, interview and talk, over 10,000, by person, company, publisher and event; each filter searches its own choices. Books opens on its table, then Browse, then Authors and Recommenders. A filter's count no longer covers its arrow.
  47. A book that no company, country or subject page lists shows its topics under Where it sits in the reference. On a phone, a page's tabs scroll sideways only. Descriptions read the same on every page. See them in the Experts tab lists every expert the page names.
  48. Every podcast episode, video and interview has its own page with a video or audio player and a link to the source. Investor pages show each company's sector and market cap; firms such as Berkshire Hathaway have one page that holds their letters and their company tabs. Letters tabs filter by company and search the theses. Companies filter by Public, Private and Defunct and link each company's website.
  49. Every tab, view and search has its own address, such as /books/table/asset or /letters/companies, so Back works and a link opens the same place. Page addresses no longer end in .html. Fund letters, Investors, Companies and Papers load about a fifth of the data they did.
  50. Fund letters has a Companies tab: every company the letters name, with its market cap, sector, country, and how many letters and investors name it. Investor pages link each investor's website. Lists in table cells end with “… and N more” at every width.
  51. 1,120 more book summaries; descriptions for 373 papers; pages for 137 more companies, each with the fund letters that discuss it; 215 official photographs; search has its own page.
  52. 411 more books have a summary; person pages list 930 more of the books they wrote; 147 people show their official photograph.
  53. Every investor has a page with its letters and the companies they discuss; company pages list the investors whose letters name them.
  54. A Companies section at the top of the rail lists every company the books, experts and fund letters name.
  55. Person pages list letters, writing, profiles and links as sortable tables with filters, and show each person's companies as links; Fund letters show each letter's description in its own column.
  56. Experts show a checked job title and a short description of each person; 30 more people have photographs.
  57. Every company, fund, university and publication the experts work for has a page listing the people there.
  58. Fund letters show each letter's thesis and filter by it; 225 person pages list the essays, columns and newsletter issues the person wrote.
  59. Person pages list every essay and newsletter issue a person wrote, and their own books as a table in List view.
  60. Recommends shows the five largest kinds of book and the rest under More; browse pictures load sooner.
  61. Podcasts and talks link the original episode, filter by Audio and video or Press, and list each publisher once.
  62. Pages are wider, Recommends has List and Grid, and a filter clicked again turns off.
  63. Book cards sit in a ruled grid with Open Library and Goodreads links and each book's one-line note.
  64. Funds is now Investors; each investor's styles are buttons that filter the table.
  65. Podcasts and talks on a person's page filter by year and publisher and show as a list or a grid of pictures.
  66. Quotes show only people's own words: 472 summaries written by list sites are gone.
  67. Country pages open from Browse again, and every link on the shelf lands on a page.
  68. Subject and person pages show their sections as tabs, and each book appears once on a person's page.
  69. Book cards show the quote, who said it and the source; grids show five cards to a row.
  70. On a phone, a menu holds the sections, search, Updates, Feedback and dark mode.
  71. Feedback takes a screenshot of the page with no browser prompt, opens a screenshot full size when you click it, and clears itself once sent.
  72. Book cards are centred, search names the topic each book sits in, and any text cut short shows whole on hover.
  73. Search groups its results by kind: people, companies, geographies, subjects, topics, books, funds, fund letters and papers.
  74. The Books table lists who recommended each book by name, and the browser tab names the section you are in.
  75. Feedback can take a screenshot of the page, or one you paste or choose, and opens in the corner beside Updates.
  76. Each rail button reopens its section where you left it, and Browse, Table and People show on every book and subject page.
  77. Filters grey out choices that hold nothing instead of hiding them, and Books › People filters by authors or recommenders.
  78. Feedback takes a subject line and up to three screenshots.
  79. Biographies are grouped by the person they are about: 41 new pages, from Abraham Lincoln to Lee Kuan Yew.
  80. Sport splits into 23 sports, and Religion into one topic per faith.
  81. Book lists show as cards: the cover, one recommendation quote and every recommender by name.
  82. Seventeen subjects that had two or three pages under different names now have one page each.
  83. Every page lists its Experts as authors and recommenders, with a link to them on the Experts tab.
  84. Economics, Financial history, Financial panics and Accounting are subjects of their own, with one page per financial crisis.
  85. Book, person and subject pages open inside the app, so the tabs stay in view.
  86. 996 more book covers, and photographs or logos for 227 more people and companies.
  87. Books › Browse shows every subject as cards, and the rail holds Fund letters, Papers, Experts, Books and Funds.
  88. Every topic over 150 books splits into narrower topics, each with a page of its own.

Send feedback

What is it?
Screenshots, up to 3 (optional)
or paste one with Ctrl+V

We use your email only to reply to you.

Deerfield Management

Asset Manager

AUM: $19.1B · Form ADV, 31 Jul 2026

i
Revolution Medicines, Inc.Nasdaq: RVMDCurrentBiological Products, (No Diagnostic Substances)COM2,124,000-268,000-11.2%0.98%$694M-$6M10.73%$34.5BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Brookdale Senior Living Inc.NYSE: BKDCurrentServices-Nursing & Personal Care FacilitiesCOM11,637,03200.0%4.86%$552M-$221M8.53%$2.1BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
CENTENE CORPNYSE: CNCCurrentHospital & Medical Service PlansCOM4,901,00000.0%0.99%$304M-$10M4.71%$32.5BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
UNITED THERAPEUTICS CorpNasdaq: UTHRCurrentPharmaceutical PreparationsCOM540,598+83,598+18.3%1.27%$293M+$45M4.53%$23.8BQ3 202616 Nov 2026Q1 2025Q3 202613F, Q3 2026
Celcuity Inc.Nasdaq: CELCCurrentServices-Medical LaboratoriesCOM2,397,664+946,650+65.2%4.88%$287M+$22M4.44%$2.8BQ3 202616 Nov 2026Q3 2025Q3 202613F, Q3 2026
Praxis Precision Medicines, Inc.Nasdaq: PRAXCurrentPharmaceutical PreparationsCOM NEW963,35100.0%3.45%$281M-$42M4.34%$8.7BQ3 202616 Nov 2026Q1 2025Q3 202613F, Q3 2026
ARROWHEAD PHARMACEUTICALS, INC.Nasdaq: ARWRCurrentPharmaceutical PreparationsCOM843,063-545,992-39.3%0.60%$261M-$93M4.03%$6.2BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
GENMAB A/SNasdaq: GMABCurrentPharmaceutical PreparationsSPONSORED ADS6,865,00000.0%$245M+$56M3.79%$31.7BQ3 202616 Nov 2026Q1 2026Q3 202613F, Q3 2026
Viatris IncNasdaq: VTRSCurrentPharmaceutical PreparationsCOM10,938,000-9,268,170-45.9%0.95%$194M-$127M3.00%$22.8BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Cogent BiosciencesNasdaq: COGTCurrentPharmaceutical PreparationsCOM5,957,000+950,896+19.0%3.42%$191M-$3M2.95%$4.8BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
IONIS PHARMACEUTICALS INCNasdaq: IONSCurrentPharmaceutical PreparationsCOM2,660,669+681,000+34.4%1.60%$185M-$65M2.86%$4.5BQ3 202616 Nov 2026Q3 2025Q3 202613F, Q3 2026
Legend Biotech CorpNasdaq: LEGNCurrentPharmaceutical PreparationsSPONSORED ADS8,137,63800.0%$162M-$73M2.50%$3.1BQ3 202616 Nov 2026Q4 2024Q3 202613F, Q3 2026
Vera Therapeutics, Inc.Nasdaq: VERACurrentPharmaceutical PreparationsCL A4,338,778+422,378+10.8%6.00%$140M-$28M2.17%$1.9BQ3 202616 Nov 2026Q1 2025Q3 202613F, Q3 2026
Tango Therapeutics, Inc.Nasdaq: TNGXCurrentPharmaceutical PreparationsCOM5,180,000+989,389+23.6%3.06%$129M-$2M2.00%$3.8BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
BIOCRYST PHARMACEUTICALS INCNasdaq: BCRXCurrentBiological Products, (No Diagnostic Substances)COM15,490,928+394,525+2.6%6.02%$129M-$22M2.00%$1.9BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
BIOMARIN PHARMACEUTICAL INCNasdaq: BMRNCurrentPharmaceutical PreparationsCOM2,025,146+692,310+51.9%1.05%$122M+$45M1.88%$11.9BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Larimar Therapeutics, Inc.Nasdaq: LRMRCurrentPharmaceutical PreparationsCOM35,606,97400.0%34.03%$114M+$5M1.76%$337MQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Newamsterdam Pharma CompanyCurrentORDINARY SHARES4,347,101-10,475-0.2%$105M-$42M1.62%Q3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Mineralys Therapeutics, Inc.Nasdaq: MLYSCurrentPharmaceutical PreparationsCOM3,958,00000.0%4.47%$99M-$7M1.54%$1.3BQ3 202616 Nov 2026Q2 2026Q3 202613F, Q3 2026
BOSTON SCIENTIFIC CORPNYSE: BSXCurrentSurgical & Medical Instruments & ApparatusCOM2,135,440+820,440+62.4%0.15%$93M+$37M1.44%$62.3BQ3 202616 Nov 2026Q3 2025Q3 202613F, Q3 2026
CHEMED CORPNYSE: CHECurrentServices-Home Health Care ServicesCOM182,000+152,000+506.7%1.40%$92M+$78M1.42%$7.1BQ3 202616 Nov 2026Q3 2025Q3 202613F, Q3 2026
Inspire Medical Systems, Inc.NYSE: INSPCurrentSurgical & Medical Instruments & ApparatusCOM1,296,86200.0%4.48%$90M+$32M1.39%$1.6BQ3 202616 Nov 2026Q2 2025Q3 202613F, Q3 2026
Tempus AI, Inc.Nasdaq: TEMCurrentServices-Computer Programming, Data Processing, Etc.NOTE 0.750% 7/1New$88M+$88M1.36%$10.9BQ3 202616 Nov 2026Q3 2026Q3 202613F, Q3 2026
Zenas BioPharma, Inc.Nasdaq: ZBIOCurrentPharmaceutical PreparationsNOTE 2.500% 4/0+6.7%$86M+$5M1.33%$1.7BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
BIO-RAD LABORATORIES, INC.NYSE: BIOCurrentLaboratory Analytical InstrumentsCL A226,07000.0%$85M+$19M1.32%$9.9BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Pharvaris N.V.Nasdaq: PHVSCurrentPharmaceutical PreparationsCOM2,590,000-786,042-23.3%$82M-$35M1.27%$2.2BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Dianthus Therapeutics, Inc. /DE/Nasdaq: DNTHCurrentPharmaceutical PreparationsCOM914,000-211,313-18.8%1.62%$80M-$29M1.24%Q3 202616 Nov 2026Q1 2026Q3 202613F, Q3 2026
IDEAYA Biosciences, Inc.Nasdaq: IDYACurrentPharmaceutical PreparationsCOM2,003,000-711,503-26.2%2.07%$77M-$24M1.19%$2.5BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Syndax Pharmaceuticals IncNasdaq: SNDXCurrentPharmaceutical PreparationsCOM3,779,90000.0%4.23%$71M-$12M1.10%$822MQ3 202616 Nov 2026Q1 2026Q3 202613F, Q3 2026
Alignment Healthcare, Inc.Nasdaq: ALHCCurrentHospital & Medical Service PlansCOM1,172,418-31.9%0.56%$71M-$33M1.09%$1.4BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Savara IncNasdaq: SVRACurrentPharmaceutical PreparationsCOM13,569,00000.0%6.15%$70M-$14M1.08%$1.1BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Certara, Inc.Nasdaq: CERTCurrentServices-Prepackaged SoftwareCOM7,512,92800.0%4.93%$69M+$20M1.07%$1.6BQ3 202616 Nov 2026Q1 2025Q3 202613F, Q3 2026
Acadia Healthcare Company, Inc.Nasdaq: ACHCCurrentServices-Specialty Outpatient Facilities, NECCOM2,493,589-2,026,411-44.8%2.68%$69M-$65M1.06%$3.2BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
AdaptHealth Corp.Nasdaq: AHCOCurrentServices-Home Health Care ServicesCOMMON STOCK11,477,73000.0%8.41%$65M-$55M1.00%$990MQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Parabilis Medicines, Inc.Nasdaq: PBLSCurrentPharmaceutical PreparationsCOM1,880,70400.0%$61M+$9M0.94%$3.5BQ3 202616 Nov 2026Q2 2026Q3 202613F, Q3 2026
Xenon Pharmaceuticals Inc.Nasdaq: XENECurrentPharmaceutical PreparationsCOM1,615,69600.0%1.64%$60M-$37M0.93%$3.7BQ3 202616 Nov 2026Q2 2025Q3 202613F, Q3 2026
Envista Holdings CorpNYSE: NVSTCurrentDental Equipment & SuppliesCOM2,210,10000.0%1.38%$52M-$6M0.80%$3.7BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Stoke Therapeutics, Inc.Nasdaq: STOKCurrentPharmaceutical PreparationsCOM1,823,50000.0%2.79%$47M-$12M0.73%$1.8BQ3 202616 Nov 2026Q4 2025Q3 202613F, Q3 2026
ZoetisNYSE: ZTSCurrentPharmaceutical PreparationsCL A632,000+632,000New0.16%$44M+$44M0.68%$32.1BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
LivaNova PLCNasdaq: LIVNCurrentElectromedical & Electrotherapeutic ApparatusNOTE 2.500% 3/1-5.4%$44M-$3M0.68%$5.1BQ3 202616 Nov 2026Q2 2025Q3 202613F, Q3 2026
Disc Medicine, Inc.Nasdaq: IRONCurrentPharmaceutical PreparationsCOM657,00000.0%1.44%$43M-$5M0.67%$3.5BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Beta Bionics, Inc.Nasdaq: BBNXCurrentSurgical & Medical Instruments & ApparatusCOM1,903,710+579,710+43.8%3.50%$36M+$15M0.56%$724MQ3 202616 Nov 2026Q1 2025Q3 202613F, Q3 2026
Structure Therapeutics Inc.Nasdaq: GPCRCurrentPharmaceutical PreparationsSPONSORED ADS1,086,00000.0%0.51%$34M-$24M0.53%$1.2BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
ARS Pharmaceuticals, Inc.Nasdaq: SPRYCurrentPharmaceutical PreparationsCOM7,503,81200.0%7.46%$32M-$28M0.50%$338MQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
BELITE BIO, INCNasdaq: BLTECurrentPharmaceutical PreparationsSPONSORED ADS190,000-167,199-46.8%$32M-$23M0.50%$6.1BQ3 202616 Nov 2026Q4 2025Q3 202613F, Q3 2026
COOPER COMPANIES, INC.Nasdaq: COOCurrentOphthalmic GoodsCOM557,000+557,000New0.29%$31M+$31M0.49%$11.5BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
BlossomHill Therapeutics, Inc.Nasdaq: BLSMCurrentPharmaceutical PreparationsCOM1,446,000+1,446,000New4.55%$27M+$27M0.42%$458MQ3 202616 Nov 2026Q3 2026Q3 202613F, Q3 2026
Odyssey Therapeutics, Inc.Nasdaq: ODTXCurrentBiological Products, (No Diagnostic Substances)COMMON STOCK1,046,13900.0%2.18%$23M+$4M0.36%$882MQ3 202616 Nov 2026Q2 2026Q3 202613F, Q3 2026
TANDEM DIABETES CARE INCNasdaq: TNDMCurrentSurgical & Medical Instruments & ApparatusCOM NEW1,390,909+1,390,909New1.99%$23M+$23M0.35%$1.2BQ3 202616 Nov 2026Q2 2025Q3 202613F, Q3 2026
Starling Oncology, Inc.Nasdaq: STLNCurrentServices-Offices & Clinics of Doctors of MedicineCOM4,610,05200.0%4.52%$21M+$3M0.33%$324MQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Avalyn Pharma Inc.Nasdaq: AVLNCurrentPharmaceutical PreparationsCOM SHS731,00000.0%1.65%$21M-$3M0.32%$1.3BQ3 202616 Nov 2026Q2 2026Q3 202613F, Q3 2026
Alamar Biosciences, Inc.Nasdaq: ALMRCurrentLaboratory Analytical InstrumentsCOMMON STOCK600,00000.0%0.86%$20M+$4M0.32%$2.0BQ3 202616 Nov 2026Q2 2026Q3 202613F, Q3 2026
Tyra Biosciences, Inc.Nasdaq: TYRACurrentPharmaceutical PreparationsCOM732,392-284,608-28.0%1.06%$16M-$16M0.25%$1.4BQ3 202616 Nov 2026Q1 2026Q3 202613F, Q3 2026
Foghorn Therapeutics Inc.Nasdaq: FHTXCurrentPharmaceutical PreparationsCOM4,394,36700.0%7.33%$16M-$6M0.24%$107MQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Vogenx, Inc.Nasdaq: VOGXCurrentPharmaceutical PreparationsCOM635,707+635,707New4.28%$14M+$14M0.22%$190MQ3 202616 Nov 2026Q3 2026Q3 202613F, Q3 2026
Embecta Corp.Nasdaq: EMBCCurrentSurgical & Medical Instruments & ApparatusCOMMON STOCK2,534,96100.0%4.47%$14M+$6M0.22%$351MQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
BridgeBio Oncology Therapeutics, Inc.Nasdaq: BBOTCurrentPharmaceutical PreparationsCOM NEW3,138,167-1,747,279-35.8%3.91%$13M-$24M0.20%$149MQ3 202616 Nov 2026Q3 2025Q3 202613F, Q3 2026
NEOGENOMICS INCNasdaq: NEOCurrentServices-Testing LaboratoriesNOTE 0.250% 1/1+0.4%$12M+$0.0M0.19%$2.0BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
BRIGHT MINDS BIOSCIENCES INC.Nasdaq: DRUGCurrentPharmaceutical PreparationsCOM NEW236,295-46,705-16.5%$12M-$8M0.18%$204MQ3 202616 Nov 2026Q1 2026Q3 202613F, Q3 2026
Monopar TherapeuticsNasdaq: MNPRCurrentPharmaceutical PreparationsCOM NEW137,591-186,154-57.5%2.03%$11M-$19M0.17%$476MQ3 202616 Nov 2026Q3 2025Q3 202613F, Q3 2026
Adagene Inc.Nasdaq: ADAGCurrentPharmaceutical PreparationsADS2,666,66600.0%$9M-$3M0.13%$135MQ3 202616 Nov 2026Q2 2026Q3 202613F, Q3 2026
Hemab Therapeutics Holdings, Inc.Nasdaq: COAGCurrentBiological Products, (No Diagnostic Substances)COM SHS275,00000.0%0.59%$8M-$2M0.13%$1.9BQ3 202616 Nov 2026Q2 2026Q3 202613F, Q3 2026
Electra Therapeutics, Inc.Nasdaq: ETRACurrentBiological Products, (No Diagnostic Substances)COM700,000+700,000New1.11%$8M+$8M0.12%$561MQ3 202616 Nov 2026Q3 2026Q3 202613F, Q3 2026
Annexon, Inc.Nasdaq: ANNXCurrentPharmaceutical PreparationsCOM583,91300.0%$2M-$0.9M0.04%$651MQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Alector, Inc.Nasdaq: ALECCurrentBiological Products, (No Diagnostic Substances)COM1,055,19200.0%0.71%$2M-$0.2M0.03%$342MQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Edwards Lifesciences CorpNYSE: EWCurrentOrthopedic, Prosthetic & Surgical Appliances & SuppliesCOM13,70200.0%<0.01%$1M-$0.1M0.02%$59.7BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
Mirum Pharmaceuticals, Inc.Nasdaq: MIRMCurrentPharmaceutical PreparationsCOM6,02700.0%0.01%$0.5M-$0.2M0.01%$6.2BQ3 202616 Nov 2026Q3 2024Q3 202613F, Q3 2026
HUMANA INCNYSE: HUMCurrentHospital & Medical Service PlansCOM91700.0%<0.01%$0.3M-$0.0M0.01%$45.6BQ3 202616 Nov 2026Q4 2024Q3 202613F, Q3 2026
PMV Pharmaceuticals, Inc.Nasdaq: PMVPCurrentPharmaceutical PreparationsCOM8,79000.0%0.01%$0.0M+$0.0M0.00%$99MQ3 202616 Nov 2026Q2 2025Q3 202613F, Q3 2026
Nuvalent IncExitedCOM0-17,248,450-100.0%-$2.1BQ3 202616 Nov 2026Q3 2024Q2 202613F, Q2 2026
Merus N VExitedCOM0-3,046,916-100.0%-$287MQ4 202517 Feb 2026Q3 2024Q3 202513F, Q3 2025
Oscar Health, Inc.NYSE: OSCRExitedHospital & Medical Service PlansCL A0-11,649,591-100.0%-$250M$8.1BQ3 202514 Nov 2025Q3 2024Q2 202513F, Q2 2025
Accolade IncExitedNOTE 0.500% 4/0-100.0%-$131MQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
Indivior PLCExitedORD0-3,393,063-100.0%-$122MQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
Waystar Holding Corp.Nasdaq: WAYExitedServices-Computer Integrated Systems DesignCOM0-3,295,260-100.0%-$121M$5.2BQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
Kura Oncology, Inc.Nasdaq: KURAExitedPharmaceutical PreparationsCOM0-5,411,571-100.0%-$106M$675MQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
BRISTOL MYERS SQUIBB CONYSE: BMYExitedPharmaceutical PreparationsCOM0-2,337,771-100.0%-$105M$119BQ4 202517 Feb 2026Q3 2025Q3 202513F, Q3 2025
Catalyst Pharmaceuticals IncExitedCOM0-3,943,600-100.0%-$98MQ2 202614 Aug 2026Q3 2024Q1 202613F, Q1 2026
Merck & Co., Inc.NYSE: MRKExitedPharmaceutical PreparationsCOM0-1,030,000-100.0%-$86M$327BQ4 202517 Feb 2026Q3 2024Q3 202513F, Q3 2025
Lantheus Holdings, Inc.Nasdaq: LNTHExitedIn Vitro & In Vivo Diagnostic SubstancesCOM0-752,999-100.0%-$84M$6.7BQ3 202616 Nov 2026Q3 2024Q2 202613F, Q2 2026
NEUROCRINE BIOSCIENCES INCNasdaq: NBIXExitedBiological Products, (No Diagnostic Substances)COM0-610,000-100.0%-$80M$15.8BQ2 202614 Aug 2026Q3 2024Q1 202613F, Q1 2026
Day One Biopharmaceuticals IncExitedCOM0-3,723,131-100.0%-$80MQ2 202614 Aug 2026Q3 2024Q1 202613F, Q1 2026
PfizerNYSE: PFEExitedPharmaceutical PreparationsCOM0-3,040,000-100.0%-$73M$156BQ3 202616 Nov 2026Q1 2025Q2 202613F, Q2 2026
INSMED IncNasdaq: INSMExitedPharmaceutical PreparationsCOM PAR $.010-471,000-100.0%-$68M$31.7BQ4 202517 Feb 2026Q3 2024Q3 202513F, Q3 2025
Supernus, Inc.Nasdaq: SUPNExitedPharmaceutical PreparationsCOM0-1,648,895-100.0%-$68M$1.7BQ3 202616 Nov 2026Q1 2026Q2 202613F, Q2 2026
Dynavax TechnologiesExitedCOM NEW0-5,191,493-100.0%-$67MQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
Enhabit IncExitedCOM0-4,747,746-100.0%-$67MQ2 202614 Aug 2026Q3 2024Q1 202613F, Q1 2026
Owens & Minor Inc NewACCHExitedCOM0-4,911,979-100.0%-$64MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
BAXTER INTERNATIONAL INCNYSE: BAXExitedSurgical & Medical Instruments & ApparatusCOM0-1,923,100-100.0%-$58M$13.1BQ3 202514 Nov 2025Q3 2024Q2 202513F, Q2 2025
CareDx, Inc.Nasdaq: CDNAExitedServices-Medical LaboratoriesCOM0-1,997,618-100.0%-$57M$3.8BQ3 202616 Nov 2026Q3 2024Q2 202613F, Q2 2026
CVS HEALTH CorpNYSE: CVSExitedRetail-Drug Stores and Proprietary StoresCOM0-874,800-100.0%-$55M$102BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Kymera Therapeutics, Inc.Nasdaq: KYMRExitedBiological Products, (No Diagnostic Substances)COM0-561,170-100.0%-$47M$10.2BQ2 202614 Aug 2026Q4 2024Q1 202613F, Q1 2026
Alphatec Holdings, Inc.Nasdaq: ATECExitedSurgical & Medical Instruments & ApparatusNOTE 0.750% 8/0-100.0%-$47MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
Lakefront Biotherapeutics NVNasdaq: LKFTExitedPharmaceutical PreparationsSPON ADR0-1,411,000-100.0%-$39M$2.2BQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
Phreesia, Inc.NYSE: PHRExitedServices-Business Services, NECCOM0-1,999,045-100.0%-$34M$737MQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
Chimerix IncExitedCOM0-3,771,342-100.0%-$32MQ2 202514 Aug 2025Q4 2024Q1 202513F, Q1 2025
Bicara Therapeutics Inc.Nasdaq: BCAXExitedPharmaceutical PreparationsCOM0-1,795,174-100.0%-$31M$605MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
Sionna Therapeutics, Inc.Nasdaq: SIONExitedPharmaceutical PreparationsCOM0-680,916-100.0%-$30M$134MQ3 202616 Nov 2026Q1 2025Q2 202613F, Q2 2026
ModernaNasdaq: MRNAExitedBiological Products, (No Diagnostic Substances)COM-100.0%-$29M$80.7BQ1 202615 May 2026Q2 2025Q4 202513F, Q4 2025
InMode Ltd.Nasdaq: INMDExitedElectromedical & Electrotherapeutic ApparatusSHS0-1,578,708-100.0%-$28M$731MQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
VentasNYSE: VTRExitedReal Estate Investment TrustsCOM0-354,000-100.0%-$27M$46.0BQ1 202615 May 2026Q2 2025Q4 202513F, Q4 2025
Immunocore Holdings plcNasdaq: IMCRExitedBiological Products, (No Diagnostic Substances)NOTE 2.500% 2/0-100.0%-$27M$1.4BQ3 202616 Nov 2026Q1 2025Q2 202613F, Q2 2026
PACS Group, Inc.NYSE: PACSExitedServices-Skilled Nursing Care FacilitiesCOM SHS0-663,851-100.0%-$27M$6.8BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Spyre Therapeutics, Inc.Nasdaq: SYREExitedPharmaceutical PreparationsCOM NEW0-710,626-100.0%-$23M$9.3BQ1 202615 May 2026Q4 2024Q4 202513F, Q4 2025
CG Oncology, Inc.Nasdaq: CGONExitedBiological Products, (No Diagnostic Substances)COM0-850,695-100.0%-$21M$7.3BQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
BioNTech SENasdaq: BNTXExitedBiological Products, (No Diagnostic Substances)SPONSORED ADS0-174,500-100.0%-$21M$20.2BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
ALNYLAM PHARMACEUTICALS, INC.Nasdaq: ALNYExitedPharmaceutical PreparationsCOM0-67,935-100.0%-$20M$19.8BQ3 202616 Nov 2026Q3 2024Q2 202613F, Q2 2026
Establishment Labs Hldgs IncExitedCOM-100.0%-$20MQ2 202514 Aug 2025Q4 2024Q1 202513F, Q1 2025
Liquidia CorpNasdaq: LQDAExitedPharmaceutical PreparationsCOM NEW0-1,616,778-100.0%-$20M$5.1BQ3 202514 Nov 2025Q1 2025Q2 202513F, Q2 2025
Septerna, Inc.Nasdaq: SEPNExitedPharmaceutical PreparationsCOM0-861,814-100.0%-$20M$1.9BQ1 202515 May 2025Q4 2024Q4 202413F, Q4 2024
Compass Therapeutics, Inc.Nasdaq: CMPXExitedBiological Products, (No Diagnostic Substances)COM0-3,606,000-100.0%-$19M$122MQ2 202614 Aug 2026Q4 2025Q1 202613F, Q1 2026
Edgewise Therapeutics, Inc.Nasdaq: EWTXExitedPharmaceutical PreparationsCOM0-765,694-100.0%-$19MQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
Mereo BioPharma Group plcNasdaq: MREOExitedPharmaceutical PreparationsSPON ADS0-6,710,429-100.0%-$18M$44MQ3 202514 Nov 2025Q3 2024Q2 202513F, Q2 2025
Xeris Biopharma Holdings, Inc.Nasdaq: XERSExitedPharmaceutical PreparationsCOM0-22,574-100.0%-$18M$3.0BQ3 202514 Nov 2025Q1 2025Q2 202513F, Q2 2025
Kyverna Therapeutics, Inc.Nasdaq: KYTXExitedBiological Products, (No Diagnostic Substances)COM0-2,000,000-100.0%-$18M$276MQ3 202616 Nov 2026Q3 2024Q2 202613F, Q2 2026
Beam Therapeutics Inc.Nasdaq: BEAMExitedBiological Products, (No Diagnostic Substances)COM0-877,809-100.0%-$17M$2.2BQ2 202514 Aug 2025Q1 2025Q1 202513F, Q1 2025
RECURSION PHARMACEUTICALS, INC.Nasdaq: RXRXExitedBiological Products, (No Diagnostic Substances)CL A0-2,315,000-100.0%-$16M$1.7BQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
NovoCure LtdNasdaq: NVCRExitedSurgical & Medical Instruments & ApparatusORD SHS0-825,119-100.0%-$15M$1.2BQ3 202514 Nov 2025Q1 2025Q2 202513F, Q2 2025
Concentra Group Holdings Parent, Inc.NYSE: CONExitedServices-Specialty Outpatient Facilities, NECCOMMON STOCK0-650,000-100.0%-$14M$5.2BQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
Metsera IncExitedCOM0-500,000-100.0%-$14MQ2 202514 Aug 2025Q1 2025Q1 202513F, Q1 2025
Autolus Therapeutics plcNasdaq: AUTLExitedBiological Products, (No Diagnostic Substances)SPON ADS0-3,639,000-100.0%-$13M$261MQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
CorMedix Inc.Nasdaq: CRMDExitedPharmaceutical PreparationsCOM0-1,107,944-100.0%-$13M$404MQ1 202615 May 2026Q3 2025Q4 202513F, Q4 2025
SpyGlass Pharma, Inc.Nasdaq: SGPExitedSurgical & Medical Instruments & ApparatusCOM SHS0-550,000-100.0%-$12M$1.0BQ3 202616 Nov 2026Q1 2026Q2 202613F, Q2 2026
Taysha Gene Therapies, Inc.Nasdaq: TSHAExitedBiological Products, (No Diagnostic Substances)COM SHS0-2,722,165-100.0%-$12M$1.2BQ2 202614 Aug 2026Q2 2025Q1 202613F, Q1 2026
RxSight, Inc.Nasdaq: RXSTExitedOphthalmic GoodsCOM0-888,950-100.0%-$12M$193MQ3 202514 Nov 2025Q1 2025Q2 202513F, Q2 2025
OPKO HEALTH, INC.Nasdaq: OPKExitedPharmaceutical PreparationsCOM0-6,906,362-100.0%-$11M$1.2BQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
INTEGRA LIFESCIENCES HOLDINGS CORPNasdaq: IARTExitedSurgical & Medical Instruments & ApparatusCOM NEW0-794,865-100.0%-$11M$1.1BQ4 202517 Feb 2026Q3 2024Q3 202513F, Q3 2025
DELCATH SYSTEMS, INC.Nasdaq: DCTHExitedSurgical & Medical Instruments & ApparatusCOM NEW0-812,561-100.0%-$11M$669MQ3 202514 Nov 2025Q1 2025Q2 202513F, Q2 2025
Medline Inc.Nasdaq: MDLNExitedSurgical & Medical Instruments & ApparatusCOM CL A0-260,000-100.0%-$11M$49.8BQ1 202615 May 2026Q4 2025Q4 202513F, Q4 2025
Third Harmonic Bio IncExitedCOM0-1,019,700-100.0%-$10MQ1 202515 May 2025Q4 2024Q4 202413F, Q4 2024
GH Research PLCNasdaq: GHRSExitedPharmaceutical PreparationsORDINARY SHARES0-925,000-100.0%-$10M$1.3BQ2 202514 Aug 2025Q1 2025Q1 202513F, Q1 2025
Mobia Medical, Inc.Nasdaq: MOBIExitedSurgical & Medical Instruments & ApparatusCOMMON STOCK0-670,752-100.0%-$9M$395MQ3 202616 Nov 2026Q2 2026Q2 202613F, Q2 2026
Omada Health, Inc.Nasdaq: OMDAExitedServices-Health ServicesCOM0-553,107-100.0%-$9M$775MQ1 202615 May 2026Q2 2025Q4 202513F, Q4 2025
CalciMedica, Inc.Nasdaq: CALCExitedPharmaceutical PreparationsCOM NEW0-1,300,000-100.0%-$9MQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
Dyne Therapeutics, Inc.Nasdaq: DYNExitedPharmaceutical PreparationsCOM0-812,408-100.0%-$8M$3.0BQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
Prelude Therapeutics IncNasdaq: PRLDExitedPharmaceutical PreparationsCOM0-3,766,120-100.0%-$8M$261MQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Vaxcyte, Inc.Nasdaq: PCVXExitedBiological Products, (No Diagnostic Substances)COM0-225,000-100.0%-$7M$9.2BQ3 202514 Nov 2025Q3 2024Q2 202513F, Q2 2025
DocGo Inc.Nasdaq: DCGOExitedTransportation ServicesCOM0-4,622,708-100.0%-$6M$17MQ4 202517 Feb 2026Q3 2024Q3 202513F, Q3 2025
Simulations Plus IncExitedCOM0-354,089-100.0%-$6MQ3 202514 Nov 2025Q1 2025Q2 202513F, Q2 2025
SHOULDER INNOVATIONS, INC.NYSE: SIExitedSurgical & Medical Instruments & ApparatusCOMMON STOCK0-482,572-100.0%-$6M$425MQ4 202517 Feb 2026Q3 2025Q3 202513F, Q3 2025
Perspective Therapeutics, Inc.NYSE: CATXExitedPharmaceutical PreparationsCOM NEW0-2,829,413-100.0%-$6M$95MQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
VERACYTE, INC.Nasdaq: VCYTExitedServices-Medical LaboratoriesCOM0-101,000-100.0%-$6M$2.0BQ3 202616 Nov 2026Q3 2024Q2 202613F, Q2 2026
FATE THERAPEUTICS INCNasdaq: FATEExitedBiological Products, (No Diagnostic Substances)COM0-3,555,871-100.0%-$6M$123MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
NeuroPace IncNasdaq: NPCEExitedSurgical & Medical Instruments & ApparatusCOM0-500,000-100.0%-$6M$280MQ3 202514 Nov 2025Q1 2025Q2 202513F, Q2 2025
Cullinan Therapeutics, Inc.Nasdaq: CGEMExitedBiological Products, (No Diagnostic Substances)COM0-386,169-100.0%-$5M$589MQ2 202614 Aug 2026Q3 2024Q1 202613F, Q1 2026
Nkarta, Inc.Nasdaq: NKTXExitedPharmaceutical PreparationsCOM0-2,155,000-100.0%-$5M$80MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
Corvus Pharmaceuticals, Inc.Nasdaq: CRVSExitedPharmaceutical PreparationsCOM0-1,000,000-100.0%-$5M$844MQ1 202515 May 2025Q4 2024Q4 202413F, Q4 2024
Neurogene Inc.Nasdaq: NGNEExitedPharmaceutical PreparationsCOM0-446,880-100.0%-$5M$475MQ2 202514 Aug 2025Q4 2024Q1 202513F, Q1 2025
Pulmonx CorpNasdaq: LUNGExitedSurgical & Medical Instruments & ApparatusCOM0-1,890,000-100.0%-$5M$119MQ3 202514 Nov 2025Q4 2024Q2 202513F, Q2 2025
Jade Biosciences, Inc.Nasdaq: JBIOExitedPharmaceutical PreparationsCOM NEW0-531,163-100.0%-$5M$1.0BQ4 202517 Feb 2026Q3 2024Q3 202513F, Q3 2025
Prestige Consumer Healthcare Inc.NYSE: PBHExitedPharmaceutical PreparationsCOM0-69,669-100.0%-$4M$2.4BQ1 202615 May 2026Q3 2025Q4 202513F, Q4 2025
VEEVA SYSTEMS INCNYSE: VEEVExitedServices-Prepackaged SoftwareCL A COM0-17,711-100.0%-$4M$42.6BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
Hillevax IncExitedCOM0-1,882,654-100.0%-$4MQ3 202514 Nov 2025Q3 2024Q2 202513F, Q2 2025
UFP TECHNOLOGIES INCNasdaq: UFPTExitedSurgical & Medical Instruments & ApparatusCOM0-18,660-100.0%-$4M$2.3BQ4 202517 Feb 2026Q2 2025Q3 202513F, Q3 2025
RadNet, Inc.Nasdaq: RDNTExitedServices-Medical LaboratoriesCOM0-49,951-100.0%-$4M$5.5BQ1 202615 May 2026Q2 2025Q4 202513F, Q4 2025
Varex Imaging CorpNasdaq: VREXExitedElectronic Components, NECCOM0-285,207-100.0%-$4M$770MQ4 202517 Feb 2026Q3 2024Q3 202513F, Q3 2025
Merit Medical SystemsNasdaq: MMSIExitedSurgical & Medical Instruments & ApparatusCOM0-41,846-100.0%-$3M$5.1BQ4 202517 Feb 2026Q3 2024Q3 202513F, Q3 2025
Prime Medicine, Inc.Nasdaq: PRMEExitedBiological Products, (No Diagnostic Substances)COM0-896,960-100.0%-$3M$856MQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
LABCORP HOLDINGS INC.NYSE: LHExitedServices-Medical LaboratoriesCOM SHS0-13,825-100.0%-$3M$30.0BQ1 202615 May 2026Q3 2025Q4 202513F, Q4 2025
Enovis CORPNYSE: ENOVExitedOrthopedic, Prosthetic & Surgical Appliances & SuppliesCOM0-127,270-100.0%-$3M$1.5BQ1 202615 May 2026Q2 2025Q4 202513F, Q4 2025
HAEMONETICS CORPNYSE: HAEExitedSurgical & Medical Instruments & ApparatusCOM0-69,089-100.0%-$3M$5.5BQ4 202517 Feb 2026Q2 2025Q3 202513F, Q3 2025
Heartflow, Inc.Nasdaq: HTFLExitedSurgical & Medical Instruments & ApparatusCOM0-100,000-100.0%-$3M$3.9BQ4 202517 Feb 2026Q3 2025Q3 202513F, Q3 2025
Singular Genomics Systems InExitedCOM NEW0-166,162-100.0%-$3MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
QUEST DIAGNOSTICS INCNYSE: DGXExitedServices-Medical LaboratoriesCOM0-18,392-100.0%-$3M$28.5BQ1 202615 May 2026Q4 2025Q4 202513F, Q4 2025
KenvueNYSE: KVUEExitedCOM0-193,853-100.0%-$3M$37.1BQ4 202517 Feb 2026Q3 2025Q3 202513F, Q3 2025
TransMedics Group, Inc.Nasdaq: TMDXExitedElectromedical & Electrotherapeutic ApparatusCOM0-25,492-100.0%-$3M$3.3BQ1 202615 May 2026Q3 2025Q4 202513F, Q4 2025
INSULET CORPNasdaq: PODDExitedSurgical & Medical Instruments & ApparatusCOM0-10,616-100.0%-$3M$9.5BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
REVVITY, INC.NYSE: RVTYExitedLaboratory Analytical InstrumentsCOM0-33,541-100.0%-$3M$16.9BQ4 202517 Feb 2026Q3 2025Q3 202513F, Q3 2025
Biolife Solutions IncExitedCOM NEW0-120,211-100.0%-$3MQ1 202615 May 2026Q2 2025Q4 202513F, Q4 2025
Petco Health & Wellness Company, Inc.Nasdaq: WOOFExitedRetail-Retail Stores, NECCOM0-936,309-100.0%-$3M$710MQ1 202615 May 2026Q1 2025Q4 202513F, Q4 2025
STAAR SURGICAL CONasdaq: STAAExitedOphthalmic GoodsCOM PAR $0.010-96,989-100.0%-$3M$1.3BQ4 202517 Feb 2026Q3 2025Q3 202513F, Q3 2025
ORTHOPEDIATRICS CORPNasdaq: KIDSExitedSurgical & Medical Instruments & ApparatusCOM0-144,220-100.0%-$3M$849MQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
Mesa LaboratoriesNasdaq: MLABExitedIndustrial Instruments For Measurement, Display, and ControlCOM0-19,664-100.0%-$3M$750MQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
CignaNYSE: CIExitedHospital & Medical Service PlansCOM0-9,203-100.0%-$3M$71.4BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
TRUPANION, INC.Nasdaq: TRUPExitedHospital & Medical Service PlansCOM0-66,438-100.0%-$2M$1.6BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
RESMED INCNYSE: RMDExitedSurgical & Medical Instruments & ApparatusCOM0-10,104-100.0%-$2M$33.3BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
Intuitive SurgicalNasdaq: ISRGExitedOrthopedic, Prosthetic & Surgical Appliances & SuppliesCOM NEW0-5,438-100.0%-$2M$138BQ4 202517 Feb 2026Q3 2025Q3 202513F, Q3 2025
ALBANY INTERNATIONAL CORP /DE/NYSE: AINExitedBroadwoven Fabric Mills, Man Made Fiber & SilkCL A0-26,848-100.0%-$2M$1.8BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
DAVITA INC.NYSE: DVAExitedServices-Misc Health & Allied Services, NECCOM0-20,909-100.0%-$2M$9.8BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
WatersNYSE: WATExitedLaboratory Analytical InstrumentsCOM0-7,885-100.0%-$2M$86.6BQ4 202517 Feb 2026Q3 2025Q3 202513F, Q3 2025
Doximity, Inc.NYSE: DOCSExitedServices-Computer Programming ServicesCL A0-51,942-100.0%-$2M$5.3BQ1 202615 May 2026Q4 2025Q4 202513F, Q4 2025
DexcomNasdaq: DXCMExitedSurgical & Medical Instruments & ApparatusCOM0-32,943-100.0%-$2M$29.9BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
iRhythm Holdings, Inc.Nasdaq: IRTCExitedSurgical & Medical Instruments & ApparatusCOM0-12,099-100.0%-$2M$3.2BQ1 202615 May 2026Q4 2024Q4 202513F, Q4 2025
CONMED CorpNYSE: CNMDExitedElectromedical & Electrotherapeutic ApparatusCOM0-52,555-100.0%-$2M$1.4BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
Fortrea Holdings Inc.Nasdaq: FTREExitedServices-Medical LaboratoriesCOMMON STOCK0-105,470-100.0%-$2M$1.9BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Masimo CorpExitedCOM0-16,147-100.0%-$2MQ1 202615 May 2026Q4 2025Q4 202513F, Q4 2025
LEMAITRE VASCULAR INCNasdaq: LMATExitedSurgical & Medical Instruments & ApparatusCOM0-25,815-100.0%-$2M$1.7BQ1 202615 May 2026Q2 2025Q4 202513F, Q4 2025
10x Genomics, Inc.Nasdaq: TXGExitedLaboratory Analytical InstrumentsCL A COM0-126,574-100.0%-$2M$7.5BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
AtriCure, Inc.Nasdaq: ATRCExitedSurgical & Medical Instruments & ApparatusCOM0-52,076-100.0%-$2M$2.8BQ1 202615 May 2026Q2 2025Q4 202513F, Q4 2025
NvidiaNasdaq: NVDAExitedSemiconductors & Related DevicesCOM0-16,318-100.0%-$2M$3.03TQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
CENTRAL GARDEN & PET CONasdaq: CENTExitedWholesale-Miscellaneous Nondurable GoodsCOM0-53,827-100.0%-$2M$2.9BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Advanced Flower Capital Inc.Nasdaq: AFCGExitedCOM0-191,162-100.0%-$2M$74MQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Avanos Med IncExitedCOM0-167,061-100.0%-$2MQ1 202615 May 2026Q3 2025Q4 202513F, Q4 2025
CORVEL CORPNasdaq: CRVLExitedInsurance Agents, Brokers & ServiceCOM0-27,629-100.0%-$2M$4.4BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
Cardinal HealthNYSE: CAHExitedWholesale-Drugs, Proprietaries & Druggists' SundriesCOM0-8,985-100.0%-$2M$62.9BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
GoodRx Holdings, Inc.Nasdaq: GDRXExitedServices-Computer Processing & Data PreparationCOM CL A0-660,133-100.0%-$2M$1.0BQ1 202615 May 2026Q4 2024Q4 202513F, Q4 2025
Otter Tail CorpNasdaq: OTTRExitedElectric ServicesCOM0-22,452-100.0%-$2M$3.3BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Surgery Partners, Inc.Nasdaq: SGRYExitedServices-General Medical & Surgical Hospitals, NECCOM0-112,623-100.0%-$2M$3.5BQ1 202615 May 2026Q3 2024Q4 202513F, Q4 2025
ALIGN TECHNOLOGY INCNasdaq: ALGNExitedOrthopedic, Prosthetic & Surgical Appliances & SuppliesCOM0-11,000-100.0%-$2M$11.3BQ1 202615 May 2026Q2 2025Q4 202513F, Q4 2025
Addus HomeCare CorpNasdaq: ADUSExitedServices-Home Health Care ServicesCOM0-15,871-100.0%-$2M$2.3BQ1 202615 May 2026Q4 2025Q4 202513F, Q4 2025
WATSCO INCNYSE: WSOExitedWholesale-Hardware & Plumbing & Heating Equipment & SuppliesCOM0-3,401-100.0%-$2M$12.2BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Donnelley Financial Solutions, Inc.NYSE: DFINExitedServices-Miscellaneous Business ServicesCOM0-24,968-100.0%-$2M$1.6BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Under Armour, Inc.NYSE: UAAExitedApparel & Other Finishd Prods of Fabrics & Similar MatlCL A0-184,457-100.0%-$2M$1.9BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Lowe'sNYSE: LOWExitedRetail-Lumber & Other Building Materials DealersCOM0-5,913-100.0%-$2M$124BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
FIRST BANCORP /NC/Nasdaq: FBNCExitedState Commercial BanksCOM0-38,451-100.0%-$2M$2.6BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
OXFORD INDUSTRIES INCNYSE: OXMExitedMen's & Boys' Furnishgs, Work Clothg, & Allied GarmentsCOM0-18,184-100.0%-$2M$382MQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Premier IncExitedCL A0-78,878-100.0%-$2MQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
IDEX CORP /DE/NYSE: IEXExitedPumps & Pumping EquipmentCOM0-7,106-100.0%-$2M$16.7BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Becton DickinsonNYSE: BDXExitedSurgical & Medical Instruments & ApparatusCOM0-6,312-100.0%-$2M$58.0BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Privia Health Group, Inc.Nasdaq: PRVAExitedServices-Health ServicesCOM0-79,941-100.0%-$1M$3.2BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Byrna Technologies Inc.Nasdaq: BYRNExitedMiscellaneous Electrical Machinery, Equipment & SuppliesCOM NEW0-85,037-100.0%-$1MQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Andersons, Inc.Nasdaq: ANDEExitedWholesale-Farm Product Raw MaterialsCOM0-28,632-100.0%-$1M$1.6BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
MAXIMUS, INC.NYSE: MMSExitedServices-Business Services, NECCOM0-15,377-100.0%-$1M$3.2BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
OLD DOMINION FREIGHT LINE, INC.Nasdaq: ODFLExitedTrucking (No Local)COM0-7,199-100.0%-$1M$35.8BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Weave Communications, Inc.ExitedCOM0-108,555-100.0%-$1MQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Exact Sciences CorpExitedCOM0-20,341-100.0%-$1MQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
IDEXX LaboratoriesNasdaq: IDXXExitedIn Vitro & In Vivo Diagnostic SubstancesCOM0-2,643-100.0%-$1M$53.3BQ4 202414 Feb 2025Q3 2024Q3 202413F, Q3 2024
Ventyx Biosciences IncExitedCOM0-534,737-100.0%-$1MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
Twist Bioscience CorpNasdaq: TWSTExitedBiological Products, (No Diagnostic Substances)COM0-23,827-100.0%-$0.9M$7.6BQ3 202514 Nov 2025Q3 2024Q2 202513F, Q2 2025
Sotera Health CoNasdaq: SHCExitedServices-Misc Health & Allied Services, NECCOM0-45,242-100.0%-$0.5M$4.6BQ3 202514 Nov 2025Q2 2025Q2 202513F, Q2 2025
Biomx IncExitedCOM NEW0-131,272-100.0%-$0.5MQ2 202614 Aug 2026Q3 2024Q1 202613F, Q1 2026
Thermo Fisher ScientificNYSE: TMOExitedMeasuring & Controlling Devices, NECCOM0-916-100.0%-$0.4M$248BQ3 202514 Nov 2025Q2 2025Q2 202513F, Q2 2025
Veradermics, IncNYSE: MANEExitedPharmaceutical PreparationsCOMMON STOCK0-5,000-100.0%-$0.3M$5.2BQ2 202614 Aug 2026Q1 2026Q1 202613F, Q1 2026
NATIONAL HEALTHCARE CORPNYSE: NHCExitedServices-Skilled Nursing Care FacilitiesCOM0-2,926-100.0%-$0.3M$3.0BQ3 202514 Nov 2025Q2 2025Q2 202513F, Q2 2025
UNIVERSAL HEALTH SERVICES INCNYSE: UHSExitedServices-General Medical & Surgical Hospitals, NECCL B0-1,597-100.0%-$0.3M$10.1BQ3 202514 Nov 2025Q3 2024Q2 202513F, Q2 2025
Amedisys IncExitedCOM0-2,744-100.0%-$0.3MQ3 202514 Nov 2025Q3 2024Q2 202513F, Q2 2025
IQVIA HOLDINGS INC.NYSE: IQVExitedServices-Commercial Physical & Biological ResearchCOM0-1,623-100.0%-$0.3M$41.3BQ3 202514 Nov 2025Q2 2025Q2 202513F, Q2 2025
MIMEDX GROUP, INC.Nasdaq: MDXGExitedSurgical & Medical Instruments & ApparatusCOM0-39,351-100.0%-$0.2M$454MQ3 202514 Nov 2025Q3 2024Q2 202513F, Q2 2025
Medpace HoldingsNasdaq: MEDPExitedServices-Commercial Physical & Biological ResearchCOM0-736-100.0%-$0.2M$17.7BQ3 202514 Nov 2025Q2 2025Q2 202513F, Q2 2025
GENERAL MILLS INCNYSE: GISExitedGrain Mill ProductsCOM0-3,455-100.0%-$0.2M$18.4BQ1 202515 May 2025Q4 2024Q4 202413F, Q4 2024
Amphastar Pharmaceuticals, Inc.Nasdaq: AMPHExitedPharmaceutical PreparationsCOM0-9,579-100.0%-$0.2M$1.2BQ3 202514 Nov 2025Q2 2025Q2 202513F, Q2 2025
ST JOE CoNYSE: JOEExitedLand Subdividers & Developers (No Cemeteries)COM0-4,473-100.0%-$0.2M$3.7BQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
DXC Technology CoNYSE: DXCExitedServices-Computer Processing & Data PreparationCOM0-11,883-100.0%-$0.2M$2.1BQ2 202514 Aug 2025Q1 2025Q1 202513F, Q1 2025
Xponential Fitness, Inc.NYSE: XPOFExitedServices-Miscellaneous Amusement & RecreationCOM CL A0-23,097-100.0%-$0.2M$197MQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
Farmland Partners Inc.NYSE: FPIExitedReal Estate Investment TrustsCOM0-16,863-100.0%-$0.2M$386MQ2 202514 Aug 2025Q1 2025Q1 202513F, Q1 2025
HALLADOR ENERGY CONasdaq: HNRGExitedElectric ServicesCOM0-13,713-100.0%-$0.2M$468MQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
RING ENERGY, INC.NYSE: REIExitedCrude Petroleum & Natural GasCOM0-127,376-100.0%-$0.1M$276MQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
Enlink Midstream LLCExitedFundCOM UNIT REP LTD0-10,257-100.0%-$0.1MQ1 202515 May 2025Q4 2024Q4 202413F, Q4 2024
Honest Company, Inc.Nasdaq: HNSTExitedRetail-Catalog & Mail-Order HousesCOM0-20,171-100.0%-$0.1M$489MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
Emergent BioSolutions Inc.NYSE: EBSExitedPharmaceutical PreparationsCOM0-14,058-100.0%-$0.1M$265MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
Nuvation Bio Inc.NYSE: NUVBExitedPharmaceutical Preparations*W EXP 02/10/2020-212,114-100.0%-$0.1M$1.3BQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
HEARTLAND EXPRESS INCNasdaq: HTLDExitedTrucking (No Local)COM0-11,547-100.0%-$0.1M$780MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
Mfa Finl IncExitedCOM0-10,935-100.0%-$0.1MQ2 202514 Aug 2025Q1 2025Q1 202513F, Q1 2025
Backblaze, Inc.Nasdaq: BLZEExitedServices-Prepackaged SoftwareCOM CL A0-21,475-100.0%-$0.1M$459MQ2 202514 Aug 2025Q1 2025Q1 202513F, Q1 2025
Vir Biotechnology, Inc.Nasdaq: VIRExitedBiological Products, (No Diagnostic Substances)COM0-15,728-100.0%-$0.1M$1.7BQ2 202514 Aug 2025Q1 2025Q1 202513F, Q1 2025
MediaAlpha, Inc.NYSE: MAXExitedServices-Business Services, NECCL A0-10,795-100.0%-$0.1M$804MQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
UNISYS CORPNYSE: UISExitedServices-Computer Integrated Systems DesignCOM NEW0-15,627-100.0%-$0.1M$198MQ1 202515 May 2025Q4 2024Q4 202413F, Q4 2024
Butterfly Network, Inc.NYSE: BFLYExitedX-Ray Apparatus & Tubes & Related Irradiation Apparatus*W EXP 02/12/2020-744,968-100.0%-$0.1M$1.6BQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
VAALCO ENERGY INC /DE/NYSE: EGYExitedCrude Petroleum & Natural GasCOM NEW0-20,897-100.0%-$0.1M$519MQ1 202515 May 2025Q4 2024Q4 202413F, Q4 2024
MANNKIND CORPNasdaq: MNKDExitedPharmaceutical PreparationsCOM NEW0-17,380-100.0%-$0.1M$1.3BQ2 202514 Aug 2025Q3 2024Q1 202513F, Q1 2025
Hanesbrands IncExitedCOM0-10,619-100.0%-$0.1MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
DIVERSIFIED HEALTHCARE TRUSTNasdaq: DHCExitedReal Estate Investment TrustsCOM SH BEN INT0-33,892-100.0%-$0.1MQ2 202514 Aug 2025Q4 2024Q1 202513F, Q1 2025
GENWORTH FINANCIAL INCNYSE: GNWExitedLife InsuranceCOM SHS0-11,307-100.0%-$0.1M$2.8BQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
Ecovyst Inc.NYSE: ECVTExitedChemicals & Allied ProductsCOM0-10,317-100.0%-$0.1M$1.0BQ1 202515 May 2025Q4 2024Q4 202413F, Q4 2024
CERUS CORPNasdaq: CERSExitedSurgical & Medical Instruments & ApparatusCOM0-50,305-100.0%-$0.1M$384MQ1 202515 May 2025Q4 2024Q4 202413F, Q4 2024
Equity ComwlthExitedCOM SH BEN INT0-43,258-100.0%-$0.1MQ1 202515 May 2025Q4 2024Q4 202413F, Q4 2024
ACCO BRANDS CorpNYSE: ACCOExitedBlankbooks, Looseleaf Binders & Bookbindg & Relatd WorkCOM0-14,557-100.0%-$0.1M$506MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
ORASURE TECHNOLOGIES INCNasdaq: OSURExitedSurgical & Medical Instruments & ApparatusCOM0-20,898-100.0%-$0.1M$249MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
NU SKIN ENTERPRISES, INC.NYSE: NUSExitedWholesale-Drugs, Proprietaries & Druggists' SundriesCL A0-10,194-100.0%-$0.1M$184MQ1 202515 May 2025Q3 2024Q4 202413F, Q4 2024
BRC IncExitedCOM CL A0-15,029-100.0%-$0.0MQ1 202515 May 2025Q4 2024Q4 202413F, Q4 2024
Quantum Si IncExited*W EXP 06/10/2020-333,333-100.0%-$0.0MQ2 202614 Aug 2026Q3 2024Q1 202613F, Q1 2026
Surrozen, Inc./DENasdaq: SRZNExitedBiological Products, (No Diagnostic Substances)*W EXP 08/01/2030-166,666-100.0%-$0.0MQ3 202616 Nov 2026Q3 2024Q2 202613F, Q2 2026
MYRIAD GENETICS INCNasdaq: MYGNExitedIn Vitro & In Vivo Diagnostic SubstancesCOM0-505-100.0%-$0.0M$531MQ2 202614 Aug 2026Q2 2025Q1 202613F, Q1 2026